Media headlines about Innospec (NASDAQ:IOSP) have been trending positive recently, Alpha One reports. Alpha One, a service of Accern, rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Alpha One ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Innospec earned a news impact score of 0.39 on Alpha One’s scale. Alpha One also gave news coverage about the specialty chemicals company an impact score of 97 out of 100, indicating that recent media coverage is extremely likely to have an impact on the company’s share price in the next few days.

Separately, Zacks Investment Research upgraded Innospec from a “sell” rating to a “hold” rating in a research report on Tuesday, December 27th.

Shares of Innospec (NASDAQ:IOSP) traded up 2.30% during midday trading on Thursday, hitting $62.35. The stock had a trading volume of 66,077 shares. Innospec has a one year low of $44.06 and a one year high of $74.75. The company has a market capitalization of $1.50 billion, a PE ratio of 18.72 and a beta of 1.28. The firm’s 50-day moving average is $62.51 and its 200 day moving average is $65.25.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings results on Tuesday, February 14th. The specialty chemicals company reported $1.09 EPS for the quarter, beating the consensus estimate of $0.89 by $0.20. Innospec had a return on equity of 15.53% and a net margin of 10.17%. The firm earned $237.80 million during the quarter, compared to analysts’ expectations of $231.70 million. During the same period in the prior year, the firm posted $1.24 earnings per share. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. Equities analysts expect that Innospec will post $4.08 earnings per share for the current fiscal year.

In other news, CFO Ian Cleminson sold 5,157 shares of the firm’s stock in a transaction that occurred on Friday, February 17th. The stock was sold at an average price of $70.91, for a total value of $365,682.87. Following the completion of the sale, the chief financial officer now directly owns 31,470 shares of the company’s stock, valued at $2,231,537.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Patrick Williams sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, March 17th. The shares were sold at an average price of $63.01, for a total value of $189,030.00. Following the completion of the sale, the chief executive officer now directly owns 200,265 shares of the company’s stock, valued at $12,618,697.65. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 11,821 shares of company stock valued at $814,527. Insiders own 2.56% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this piece of content can be viewed at

About Innospec

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

5 Day Chart for NASDAQ:IOSP

Receive News & Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.